Phase One Pilot Study Using Magnetic Resonance Spectroscopy to Predict the Histology of Radiofrequency-Ablated Renal Tissue

MR spectroscopy can correctly diagnose the molecular absence of disease in post-RFA tissue biopsies. This proof of principle study warrants in vivo evaluation to confirm the clinical correlates of this modality.